The European Bank for induced pluripotent Stem Cells (EBiSC) is a non-profit induced pluripotent stem cell (iPSC) repository based in Germany and the UK that has collected, safeguarded and distributed >900 iPSC lines since 2014. These lines were generated in diverse research projects across the EU and USA, including StemBANCC, HipSci and IMI-ADAPTED. Through these experiences,…
The Share4Rare Project announces its 1st open call for patient-driven research projects targeted towards patient organisations and researchers in the field of rare diseases to apply for conducting their patient-centred studies within the platform. The call is currently open but will close on July 15th at 17:00 CET. Applicants who are selected can avail the following benefits: Facilitation of communication with patients, their carers…
The European Expert Group on Orphan Drug Incentives (OD Expert Group), in collaboration with media partner EURACTIV, is organising a webinar on how to address the unmet needs of rare disease patients by transforming the European Orphan Medicinal Products (OMP) landscape. The webinar will take place on June 11th from 14.30 – 16.00 CET. In this online event targeted towards the broad rare disease community,…
The European Commission (EC) is organising its annual flagship Research and Innovation event, titled « European Research and Innovation Days 2021 », bringing together policymakers, researchers, entrepreneurs and the public to debate and shape the future of research and innovation in Europe and beyond. The online event will take place over two days from June 23rd – 24th from 09.00 – 18.00 CET. The event programme consists…
The European Open Science Cloud (EOSC) Secretariat is organising a symposium on the theme of « Implementing an inclusive European Open Science Cloud », representing an inclusive platform for all open science community stakeholders to share objectives, visions, activities and results in order to shape the future of the EOSC that is now in the implementation phase…
The Share4Rare Consortium is organising a webinar to share the findings and outputs of four years of the Share4Rare project, setting the base for the next generation of data sharing in rare diseases. The webinar will take place on June 8th from 15.00 – 18.00 CET. In this online event targeted towards rare disease patients and their families, patient…
EURORDIS is pleased to announce that nominations for the EURORDIS Black Pearl Awards 2022 are now open. The Awards are presented to patient advocates and organisations, policy makers, scientists, companies, and media in recognition of their exceptional achievements and outstanding commitment to the rare disease cause. NOMINATIONS: Just like every year, you can nominate any individual or organisation from anywhere in the world (including yourself and/or your own organisation) whose…
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is hosting a multi-stakeholder virtual workshop titled « Accelerating Adoption of Complex Clinical Trials in Europe and Beyond » aimed at developing shared solutions for the use of complex clinical trials to optimise drug development in Europe. The online event will take place over two days: October 5th from 14.00 – 19.00 CET and October 6th from 14.00…
Based on evidence from a single-arm clinical trial, the European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European Union for the gene therapy SKYSONA™ for the treatment of children with cerebral adrenoleukodystrophy (CALD), a severe form of a rare inherited neurological disease. SKYSONA™, developed by bluebird bio, is a one-time treatment which can…
Findacure, a UK-based nonprofit that works in the rare disease sector, is organising its annual Drug Repurposing for Rare Diseases Conference 2021, which will be a fully online event bringing together patient groups, researchers, medical professionals and industry representatives to showcase innovative repurposing projects and encourage conversation between all members of the rare disease community. …